Methods for reducing platelet aggregation and treating cardiovascular disease and other medical disorders
AssigneeParadise Health, Inc.
InventorsCurt Hendrix, Jack Joseph Kleid
Life of this patent
Estimating the term…
Abstract
The invention provides therapeutic compositions containing ground seed of Aframomum meleguata or an extract thereof, and methods for using such compositions to reduce platelet aggregation and treat medical disorders in a patient, such as cardiovascular disease.
Claims22
A method of treating cardiovascular disease in a patient, comprising orally administering to a patient in need thereof an effective amount of a therapeutic composition comprising ground seed of Aframomum melegueta or an extract thereof, to treat the cardiovascular disease, wherein there is a reduction in the incidence of platelet aggregation caused by arachidonic acid, there is a reduction in the incidence of platelet aggregation caused by adenosine diphosphate, and there is a reduction in the incidence of platelet aggregation caused by collagen.
A method of reducing the risk of cardiovascular disease attributed to platelet aggregation in a patient, comprising orally administering to a patient in need thereof an effective amount of a therapeutic composition comprising ground seed of Aframomum melegueta or an extract thereof, to reduce the risk of cardiovascular disease attributed to platelet aggregation, wherein the cardiovascular disease attributed to platelet aggregation is acute coronary syndrome, myocardial infarction, stroke, peripheral arterial disease, transient ischemic attack, or angina, in each instance attributed to platelet aggregation, and there is a reduction in the incidence of platelet aggregation caused by arachidonic acid, there is a reduction in the incidence of platelet aggregation caused by adenosine diphosphate, and there is a reduction in the incidence of platelet aggregation caused by collagen.
Dependencies are inferred from the claim text.